Thomas A. Pieters
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Thomas A. Pieters has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Adam G. Kelly
Department of Neurology, University of Florida College of Medicine, Gainesville, FL
1 shared publication - Benjamin P. George
Department of Neurosurgery, University of Rochester
1 shared publication Bharat Guthikonda
Department of Neurosurgery, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA
1 shared publication- Christopher Zammit
School of Medicine and Dentistry, University of Rochester Medical Center, 601 Elmwood Ave, Box 655C, Rochester, NY, 14642, USA
1 shared publication - Clemens Maria Schirmer
Department of Neurosurgery, Geisinger, Danville, Pennsylvania, USA
1 shared publication James Towner
Department of Neurosurgery, University of Rochester, 601 Elmwood Avenue, Rochester, NY, 14642, United States
1 shared publication
Latest Publications
- 1 July 2021
- Published by Elsevier in World Neurosurgery
- Vol. 151, 364-369
Credentialing, Certification, and Peer Review Essentials for the Neurosurgeon
- 1 July 2021
- Published by Elsevier in World Neurosurgery
- Vol. 151, 364-369
Credentialing, Certification, and Peer Review Essentials for the Neurosurgeon
- 1 April 2019
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 28 (4) , 980-987
Trends in Interhospital Transfers and Mechanical Thrombectomy for United States Acute Ischemic Stroke Inpatients
- 1 April 2019
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 28 (4) , 980-987
Trends in Interhospital Transfers and Mechanical Thrombectomy for United States Acute Ischemic Stroke Inpatients
- Open Access
- 7 July 2018
- Published by Scientific Scholar in American Journal of Interventional Radiology
- Vol. 2 (9) , 1-5
A History of Mobile Stroke Units and Review of Literature
Using intravenous tissue plasminogen activator (IV tPA), improved functional outcomes are seen with earlier initiation of treatment. Recent studies have shown endovascular revascularization to be a revolutionary and effective treatment. There have been many initiatives focused on improving public education and awareness of stroke symptoms. The concept of a mobile stroke unit (MSU) was created as a way of bringing treatment to patients. Earlier CT scans, delivery of tPA, proper triage and on-scene goal-directed care were the primary goals with these units. It was thought that rapid implementation would shorten hospital stay and improve outcomes. The University of Saarland found a decrease of 41 minutes from stroke alarm to therapeutic decision when an MSU was used. A second trial found a decrease of 25 minutes in time to treatment, an increase in the rate of thrombolysis utilization, and no change in the rates of intracranial hemorrhage or 7-day mortality when an MSU was employed. In 2016, a Lancet article showed that 3 month modified Rankin Scale (mRS) and 3-month mortality were improved in MSU patients. Finally, starting thrombolytic therapy in the MSU was associated with higher probability of mRS of 0-3 but not an improved 3-month survival rate. Long-term results are thus far not available precluding an effective cost-benefit analysis. Many study results are not generalizable as they compare a single hospital system and specialized MSU team to conventional care delivered by a multiple healthcare systems. Future studies will target these limitations.
- 7 July 2018
- Published by Scientific Scholar in American Journal of Interventional Radiology
- Vol. 2 (9) , 1-5
Open AccessA History of Mobile Stroke Units and Review of Literature
Using intravenous tissue plasminogen activator (IV tPA), improved functional outcomes are seen with earlier initiation of treatment. Recent studies have shown endovascular revascularization to be a revolutionary and effective treatment. There have been many initiatives focused on improving public education and awareness of stroke symptoms. The concept of a mobile stroke unit (MSU) was created as a way of bringing treatment to patients. Earlier CT scans, delivery of tPA, proper triage and on-scene goal-directed care were the primary goals with these units. It was thought that rapid implementation would shorten hospital stay and improve outcomes. The University of Saarland found a decrease of 41 minutes from stroke alarm to therapeutic decision when an MSU was used. A second trial found a decrease of 25 minutes in time to treatment, an increase in the rate of thrombolysis utilization, and no change in the rates of intracranial hemorrhage or 7-day mortality when an MSU was employed. In 2016, a Lancet article showed that 3 month modified Rankin Scale (mRS) and 3-month mortality were improved in MSU patients. Finally, starting thrombolytic therapy in the MSU was associated with higher probability of mRS of 0-3 but not an improved 3-month survival rate. Long-term results are thus far not available precluding an effective cost-benefit analysis. Many study results are not generalizable as they compare a single hospital system and specialized MSU team to conventional care delivered by a multiple healthcare systems. Future studies will target these limitations.